Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2026)
Orthopediatrics has reported Cash & Current Investments over the past 12 years, most recently at $48.8 million for Q1 2026.
- For Q1 2026, Cash & Current Investments rose 37.77% year-over-year to $48.8 million; the TTM value through Mar 2026 reached $48.8 million, up 37.77%, while the annual FY2025 figure was $21.6 million, 52.77% down from the prior year.
- Cash & Current Investments for Q1 2026 was $48.8 million at Orthopediatrics, up from $21.6 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $118.3 million in Q4 2022 and troughed at $1.4 million in Q3 2022.
- A 5-year average of $43.4 million and a median of $38.6 million in 2022 define the central range for Cash & Current Investments.
- Biggest five-year swings in Cash & Current Investments: plummeted 97.49% in 2022 and later skyrocketed 744.17% in 2023.
- Year by year, Cash & Current Investments stood at $118.3 million in 2022, then crashed by 32.11% to $80.3 million in 2023, then tumbled by 43.0% to $45.8 million in 2024, then tumbled by 52.77% to $21.6 million in 2025, then surged by 125.76% to $48.8 million in 2026.
- Business Quant data shows Cash & Current Investments for KIDS at $48.8 million in Q1 2026, $21.6 million in Q4 2025, and $18.9 million in Q3 2025.